Clinical Study

Dysregulation of Vascular Endothelial Progenitor Cells Lung-Homing in Subjects with COPD

Table 1

Subject characteristics of COPD patients and normal subjects.

CharacteristicCOPD patients ()Normal subjects ()

Age, years31.3 ± 4.5
Gender, % male85.742.9
BMI, kg⋅m226.7 ± 4.627.2 ± 5.2
Smoking status
 Current, %66.70.0
 Ex-smoker, %33.316.7
 Nonsmoker, %0.083.3
 Cigarette pack-years 60.6 ± 22.31.3 ± 2.2
Comorbidities
 Hypertension, %25.00.0
 Hyperlipidemia, %25.00.0
Statin use, %16.70.0
Pulmonary function
 FEV1
 Prebronchodilator,
 % predicted
40.4 ± 20.1101.8 ± 15.2
 FEV1
 Postbronchodilator,
 % predicted
47.6 ± 11.5109.0 ± 14.1
 FVC
 Prebronchodilator,
 % predicted
56.4 ± 13.8114.6 ± 15.2
 FVC
 Postbronchodilator,
 % predicted
0.65 ± 0.10.88 ± 0.0
 FEV1/FVC 0.61 ± 0.070.85 ± 0.03

Values are expressed as mean ± SD.
Significant difference () between groups.